Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06261034
Other study ID # 23-008765
Secondary ID 8K12AR084222-15
Status Recruiting
Phase
First received
Last updated
Start date July 2024
Est. completion date March 2027

Study information

Verified date June 2024
Source Mayo Clinic
Contact Joshua Bock, PhD
Phone (507) 422-0768
Email Bock.Joshua@mayo.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 2027
Est. primary completion date March 2027
Accepts healthy volunteers
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria: - 20-70 years of age Exclusion Criteria: - Coronary artery disease - Heart failure - Pregnancy - COPD - Diabetes - CKD - Sleep disorders other than OSA - Shift workers - Individuals who typically go to sleep after midnight - Individuals who traveled across =2 time zones within one week of study visits - BMI =40.0kg/m2 - Use of nicotine-containing products within the two years preceding study visits - Use of allopurinol, proton pump inhibitors, or other medications/supplements which interfere with outcome measures

Study Design


Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Cerebral autoregulation Measured by transcranial doppler ultrasound (cm/sec). Baseline
Other Sympathetic action potentials per burst Measured by Microneurography reported as action potentials per burst (reflecting firing rate). Baseline
Other Sympathetic action potential clusters per burst Measured by Microneurography reported as clusters per burst (reflecting recruitment of latent subpopulations). Baseline
Other Sympathetic action potential conduction latency of each cluster Measured by Microneurography reported as conduction latency of each cluster (reflecting synaptic delays and verifying larger amplitude clusters as new populations). Baseline
Other Immune function Immune function will be measured as percent of parent cell population. Baseline
Other Urinary Extracellular Vesicle Presence and Content Number of extracellular vesicles present in a 24 hour urine collection and the contents being carried by those vesicles. Baseline
Other Plasma Extracellular Vesicle Presence and Content Number of extracellular vesicles present in blood plasma sample and the contents being carried by those vesicles. Baseline
Primary Blood pressure Measured in millimeters of mercury (mmHg). Baseline
Primary Arterial stiffness Measured by applanation tonometry reported as aortic pulse wave velocity (m/sec) Baseline
Primary Endothelial function Ultrasound assessment of flow-mediated vasodilation of the brachial artery. Brachial artery diameter and blood velocity will be measured after deflation to measure endothelial function. Baseline
Secondary Sympathetic nerve burst frequency Measured by Microneurography reported as number of nerve bursts per minute (burst/min) Baseline
Secondary Sympathetic nerve burst incidence Measured by Microneurography reported as number of nerve burst per 100 heart beats (burst/100 heart beats) Baseline
Secondary Sympathetic nerve burst amplitude (AU) Measured by Microneurography reported in arbitrary units (AU) Baseline
Secondary Total muscle sympathetic nerve activity (MSNA) Measured by Microneurography reported burst arbitrary units per minute (AU/min) Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A